Literature DB >> 11870021

Orlistat misuse in bulimia nervosa.

Shishuka Malhotra, Susan L McElroy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11870021     DOI： 10.1176/appi.ajp.159.3.492-a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  3 in total

1.  Over-the-counter orlistat: early experiences, views and attitudes of community pharmacists in Great Britain.

Authors:  Anita Elaine Weidmann; Scott Cunningham; Gwen Gray; Denise Hansford; James McLay; John Broom; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2011-05-15

2.  A prevalence study and description of alli use by patients with eating disorders.

Authors:  Kristine J Steffen; James E Mitchell; Daniel le Grange; Scott J Crow; Evelyn Attia; Cynthia M Bulik; Jocilyn E Dellava; Ovidio Bermudez; Ann L Erickson; Ross D Crosby; Vidhu P Bansal-Dev
Journal:  Int J Eat Disord       Date:  2010-07       Impact factor: 4.861

Review 3.  Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Francisco Romo-Nava
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.